ZURALO Trademark

Trademark Overview

On Tuesday, March 1, 2016, a trademark application was filed for ZURALO with the United States Patent and Trademark Office. The USPTO has given the ZURALO trademark a serial number of 86924523. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, February 12, 2019. This trademark is owned by AstraZeneca AB. The ZURALO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation
zuralo

General Information

Serial Number86924523
Word MarkZURALO
Filing DateTuesday, March 1, 2016
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, February 12, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 4, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE

Trademark Events

Event DateEvent Description
Tuesday, February 12, 2019ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, February 12, 2019ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, February 8, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 5, 2018NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, July 5, 2018INQUIRY TO SUSPENSION E-MAILED
Thursday, July 5, 2018SUSPENSION INQUIRY WRITTEN
Tuesday, May 22, 2018LIE CHECKED SUSP - TO ATTY FOR ACTION
Wednesday, November 15, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, November 15, 2017LETTER OF SUSPENSION E-MAILED
Wednesday, November 15, 2017SUSPENSION LETTER WRITTEN
Thursday, September 21, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 21, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 19, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, April 3, 2017NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, April 3, 2017INQUIRY TO SUSPENSION E-MAILED
Monday, April 3, 2017SUSPENSION INQUIRY WRITTEN
Monday, March 13, 2017LIE CHECKED SUSP - TO ATTY FOR ACTION
Tuesday, September 6, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, September 6, 2016LETTER OF SUSPENSION E-MAILED
Tuesday, September 6, 2016SUSPENSION LETTER WRITTEN
Tuesday, August 16, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 16, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, August 13, 2016ASSIGNED TO LIE
Friday, August 5, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 28, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 28, 2016NON-FINAL ACTION E-MAILED
Monday, March 28, 2016NON-FINAL ACTION WRITTEN
Monday, March 21, 2016ASSIGNED TO EXAMINER
Friday, March 4, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, March 4, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

zuralo diseases disorders substances preparations pharmaceutical nervous system inflammation infection gastrointestinal